SC-26196

N/A

Report date: 2025/05/22 10:35:18
NME

Base Information

Drug NameSC-26196
Drug Alias NameSC-26196
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFADS2 inhibitors
TargetsFADS2
Therapy Area/IndicationsEdema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGD Searle LLC
China Registration ClassN/A

Develop Information

Active CompaniesGD Searle LLC
Inactive CompaniesN/A
Active IndicationsEdema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A